DK1942933T3 - Hundeinfluenzavacciner - Google Patents

Hundeinfluenzavacciner

Info

Publication number
DK1942933T3
DK1942933T3 DK06789953.4T DK06789953T DK1942933T3 DK 1942933 T3 DK1942933 T3 DK 1942933T3 DK 06789953 T DK06789953 T DK 06789953T DK 1942933 T3 DK1942933 T3 DK 1942933T3
Authority
DK
Denmark
Prior art keywords
dogs
influenza vaccines
influenza
vaccines
dogs influenza
Prior art date
Application number
DK06789953.4T
Other languages
English (en)
Inventor
Jules Maarten Minke
Kemal Karaca
Jiansheng Yao
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/211,983 external-priority patent/US7384642B2/en
Application filed by Merial Ltd filed Critical Merial Ltd
Application granted granted Critical
Publication of DK1942933T3 publication Critical patent/DK1942933T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK06789953.4T 2005-08-25 2006-08-23 Hundeinfluenzavacciner DK1942933T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/211,983 US7384642B2 (en) 2005-08-25 2005-08-25 Canine influenza vaccines
US11/264,622 US7425336B2 (en) 2005-08-25 2005-11-01 Canine influenza vaccines
PCT/US2006/032914 WO2007024947A2 (en) 2005-08-25 2006-08-23 Canine influenza vaccines

Publications (1)

Publication Number Publication Date
DK1942933T3 true DK1942933T3 (da) 2013-01-14

Family

ID=37772325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06789953.4T DK1942933T3 (da) 2005-08-25 2006-08-23 Hundeinfluenzavacciner

Country Status (11)

Country Link
US (1) US7425336B2 (da)
EP (1) EP1942933B1 (da)
JP (1) JP2009506050A (da)
CA (1) CA2620074C (da)
CY (1) CY1113540T1 (da)
DK (1) DK1942933T3 (da)
ES (1) ES2397707T3 (da)
PL (1) PL1942933T3 (da)
PT (1) PT1942933E (da)
SI (1) SI1942933T1 (da)
WO (1) WO2007024947A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20080241184A1 (en) * 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
NZ566490A (en) * 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
PT2368572T (pt) * 2005-11-04 2020-06-16 Seqirus Uk Ltd Vacinas com adjuvante dotadas de antigénios não-virião preparados a partir de vírus da gripe cultivado em cultura celular
US8697087B2 (en) * 2005-11-04 2014-04-15 Novartis Ag Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2396032B1 (en) 2009-02-10 2016-09-28 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene
ES2588183T3 (es) * 2009-03-31 2016-10-31 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal
WO2011094693A1 (en) * 2010-02-01 2011-08-04 Mount Sinai School Of Medicine Interferon-inducing compounds and uses thereof
CA3018230A1 (en) 2011-03-14 2012-09-20 Boehringer Ingelheim Vetmedica, Inc. Equine rhinitis b vaccine
MA42656A (fr) * 2015-08-20 2018-06-27 Univ Cornell Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
EP3463439B1 (en) 2016-06-03 2022-08-03 University of Rochester Equine influenza virus live-attenuated vaccines
JP7018941B2 (ja) 2016-06-17 2022-02-14 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 直鎖または分枝ポリアクリル酸ポリマーアジュバントを含む新規な免疫原性処方物
CA3087239A1 (en) 2018-02-27 2019-09-06 University Of Rochester Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756430A (en) * 1980-09-19 1982-04-05 Biseibutsu Kagaku Kenkyusho:Kk Live virus vaccine for canine parainfluenza
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
JP2001151698A (ja) * 1999-09-10 2001-06-05 Nichiko Pharmaceutical Co Ltd インフルエンザワクチン
CN107099512A (zh) * 2005-04-21 2017-08-29 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法

Also Published As

Publication number Publication date
CA2620074C (en) 2014-07-15
ES2397707T3 (es) 2013-03-08
US20070048821A1 (en) 2007-03-01
PL1942933T3 (pl) 2013-03-29
US7425336B2 (en) 2008-09-16
WO2007024947A2 (en) 2007-03-01
JP2009506050A (ja) 2009-02-12
CY1113540T1 (el) 2016-06-22
CA2620074A1 (en) 2007-03-01
SI1942933T1 (sl) 2013-02-28
PT1942933E (pt) 2013-01-24
EP1942933B1 (en) 2012-10-17
EP1942933A2 (en) 2008-07-16
WO2007024947A3 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
DK1942933T3 (da) Hundeinfluenzavacciner
DK1968631T3 (da) Vaccine
DK1926496T3 (da) PCV-2-vaccine
ATE450271T1 (de) Impfstoff
DK2422810T3 (da) Influenzavaccine
DK1959991T3 (da) Terapeutisk vaccine
DK1957528T3 (da) Nukleotid-vaccine
ATE477250T1 (de) Cyanoanthranilamidinsektizide
DK2200646T3 (da) RNA-Vacciner
FR2882056B1 (fr) Dipyrromethenes-bore borocarbones insatures
DE602006012066D1 (de) Daraus
DK2114993T3 (da) Vaccine
DK1957073T3 (da) Lægemiddel
DK2069503T3 (da) Papayamosaikvirus-baserede vacciner mod influenza
DE602006015649D1 (de) Gehhilfsvorrichtung
DK1848727T3 (da) Ibandronat polymorf b
DE602006001073D1 (de) Viehmarke
DE602006008430D1 (de) Fikationseinrichtung
DK1877549T3 (da) HIV-vaccine
AT501523A3 (de) Estrich
DE602005007465D1 (de) Dispersionssteigungskompensator
DE502005002721D1 (de) Flanschdichtung
AT502106A3 (de) Gegenstände
FR2882055B1 (fr) Dibenzopyrromethenes-bore borocarbones insatures
ITMI20062006A1 (it) Dispositivo di arresto